Put companies on watchlist
Johnson & Johnson
ISIN: US4781601046
WKN: 853260
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Johnson & Johnson · ISIN: US4781601046 · Business Wire (ID: 20241004735017)
04 October 2024 10:30PM

Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference


Johnson & Johnson (NYSE: JNJ) will participate in the Guggenheim Global Healthcare Conference on Tuesday, November 12th, at the InterContinental Boston in Boston, MA. Biljana Naumovic, President, Solid Tumor, U.S. Oncology and Mark Wildgust, Vice President, Global Medical Affairs Oncology, will represent the Company in a session scheduled at 10:30 a.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48 hours after the webcast.

Contact

Media contact:
media-relations@its.jnj.com

Investor contact:
investor-relations@its.jnj.com

Visual performance / price development - Johnson & Johnson
Smart analysis and research tools can be found here.
This publication was provided by our content partner Business Wire
BusinessWire
via BusinessWire - Newsfeed
BusinessWire ©2024
BusinessWire
Contact:
101 California Street, 20th Floor San Francisco, CA, 94111 United States
+1.415.986.4422